Edward J. Goetzl
#84,168
Most Influential Person Now
Edward J. Goetzl's AcademicInfluence.com Rankings
Edward J. Goetzlphilosophy Degrees
Philosophy
#3001
World Rank
#4947
Historical Rank
Ontology
#15
World Rank
#19
Historical Rank
Logic
#901
World Rank
#1467
Historical Rank
Edward J. Goetzlbiology Degrees
Biology
#3573
World Rank
#5444
Historical Rank
Immunology
#147
World Rank
#155
Historical Rank
Biochemistry
#343
World Rank
#413
Historical Rank
Download Badge
Philosophy Biology
Edward J. Goetzl's Degrees
- Masters Medicine University of California, San Francisco
- PhD Biochemistry University of California, San Francisco
Why Is Edward J. Goetzl Influential?
(Suggest an Edit or Addition)Edward J. Goetzl's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network (2005) (708)
- Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study (2015) (579)
- Matrix metalloproteinases in immunity. (1996) (568)
- Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid* (1998) (550)
- The immunosuppressant FTY720 down‐regulates sphingosine 1‐phosphate G protein‐coupled receptors (2004) (541)
- Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate (1998) (527)
- International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature (2002) (482)
- O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. (1986) (475)
- The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs). (1980) (469)
- Specific stimulation of human T lymphocytes by substance P. (1983) (468)
- Molecular and cellular mechanisms of leukocyte chemotaxis. (1981) (398)
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. (1980) (334)
- Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. (1977) (328)
- Leukotriene B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. (1984) (315)
- Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease (2015) (309)
- Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. (1985) (289)
- Modulation of immunity and hypersensitivity by sensory neuropeptides. (1984) (286)
- Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases 1 (1995) (285)
- Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. (1983) (283)
- Identification of cDNAs encoding two G protein‐coupled receptors for lysosphingolipids 1 (1997) (263)
- Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes (2017) (258)
- Substance P recognition by a subset of human T lymphocytes. (1984) (256)
- Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. (2001) (254)
- Activation‐regulated expression and chemotactic function of sphingosine 1‐phosphate receptors in mouse splenic T cells (2002) (252)
- Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes. (1982) (252)
- Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system (1989) (249)
- Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile (2016) (243)
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural‐derived blood exosomes of preclinical Alzheimer's disease (2015) (243)
- Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease (2016) (240)
- Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing. (2000) (239)
- Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. (1997) (238)
- Generation of unique mono-hydroxy-eicosatetraenoic acids from arachidonic acid by human neutrophils (1979) (236)
- Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax. (1999) (231)
- Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs (1987) (227)
- Leukotriene B4 and phosphatidic acid are calcium ionophores. Studies employing arsenazo III in liposomes. (1982) (222)
- Cargo proteins of plasma astrocyte‐derived exosomes in Alzheimer's disease (2016) (218)
- Respiratory gases of synovial fluids. An approach to synovial tissue circulatory-metabolic imbalance in rheumatoid arthritis. (1970) (213)
- Specific binding of phospholipid platelet-activating factor by human platelets. (1982) (212)
- Characteristics of the cofactor requirements for the superoxide-generating NADPH oxidase of human polymorphonuclear leukocytes. (1981) (209)
- Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response (1984) (202)
- Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. (1975) (199)
- High complement levels in astrocyte‐derived exosomes of Alzheimer disease (2018) (198)
- Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. (1993) (193)
- Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer. (1999) (192)
- Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. (1982) (189)
- Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. (1996) (189)
- The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. (2001) (186)
- Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. (2002) (185)
- Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. (1984) (181)
- Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. (1974) (179)
- Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes (1985) (178)
- Novel structural determinants of the human neutrophil chemotactic activity of leukotriene B (1981) (177)
- Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. (1997) (175)
- Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. (1995) (172)
- Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid. (1978) (172)
- Recombinant human G protein-coupled lysophosphatidic acid receptors mediate intracellular calcium mobilization. (1998) (172)
- Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts. (1984) (172)
- Distinct subsets of somatostatin receptors on cultured human lymphocytes. (1989) (166)
- Selective generation of leukotriene B4 by tracheal epithelial cells from dogs. (1983) (164)
- Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. (1981) (160)
- Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. (1975) (159)
- Type 4 sphingosine 1‐phosphate G protein‐coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration (2005) (158)
- Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. (2002) (157)
- Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide. (1970) (156)
- Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. (1980) (151)
- Sphingosine Kinase Activation Mediates Ischemic Preconditioning in Murine Heart (2004) (150)
- Low neural exosomal levels of cellular survival factors in Alzheimer’s disease (2015) (147)
- Selective localization of vasoactive intestinal peptide and substance P in human eosinophils. (1987) (147)
- Modulation of Pro-inflammatory Gene Expression by Nuclear Lysophosphatidic Acid Receptor Type-1* (2003) (145)
- Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors. (1974) (144)
- Cloning and expression of the human vasoactive intestinal peptide receptor. (1991) (141)
- Modulation of lymphocyte function by sensory neuropeptides. (1985) (141)
- Tumor-associated eosinophilotactic factor. (1974) (140)
- Cutting Edge: Suppression of T Cell Chemotaxis by Sphingosine 1-Phosphate1 (2002) (139)
- Neuropeptide regulation of the expression of immediate hypersensitivity. (1985) (138)
- Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. (2007) (137)
- Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. (2004) (136)
- Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide (2001) (135)
- Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids (1995) (135)
- Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents. (1980) (134)
- Selective feed-back inhibition of the 5-lipoxygenation of arachidonic acid in human T-lymphocytes. (1981) (133)
- Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. (1983) (131)
- Gelsolin Binding and Cellular Presentation of Lysophosphatidic Acid* (2000) (127)
- The regulation of human eosinophil function by endogenous mono-hydroxy-eicosatetraenoic acids (HETEs). (1980) (126)
- Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. (1984) (125)
- Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2. (1993) (125)
- Isolation of human eosinophil phospholipase D. (1976) (123)
- Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid. (1986) (123)
- Neuropeptide Modulation of Leukocyte Function a (1987) (123)
- Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). (1978) (121)
- Isoforms of the EP3 subtype of human prostaglandin E2 receptor transduce both intracellular calcium and cAMP signals. (1994) (120)
- Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other polyarthritides. (1987) (120)
- Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease (2017) (120)
- Signaling mechanisms and molecular characteristics of G protein‐coupled receptors for lysophosphatidic acid and sphingosine 1‐phosphate (1998) (120)
- Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. (1980) (117)
- Functional characterization of synthetic leukotriene B and its stereochemical isomers (1981) (117)
- Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate1 (2007) (117)
- Accumulation of leukotriene C4 and histamine in human allergic skin reactions. (1985) (116)
- Mediators of communication and adaptation in the neuroendocrine and immune systems (1992) (111)
- Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor. (1997) (108)
- Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. (1994) (107)
- Dual mechanisms for lysophospholipid induction of proliferation of human breast carcinoma cells. (1999) (106)
- Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging. (2019) (106)
- Unique aspects of the modulation of human neutrophil function by 12-L-hydroperoxy-5,8,10,14-eicosatetraenoic acid. (1980) (105)
- Specific suppression of human T lymphocyte function by leukotriene B4. (1983) (105)
- Transduction of Multiple Effects of Sphingosine 1-Phosphate (S1P) on T Cell Functions by the S1P1 G Protein-Coupled Receptor 1 (2003) (104)
- Preformed eosinophil chemotactic factor of anaphylaxis (ECF-A). (1974) (104)
- The release of four mediators of immediate hypersensitivity from human leukemic basophils. (1975) (104)
- Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. (1981) (102)
- Cutting Edge: Differential Constitutive Expression of Functional Receptors for Lysophosphatidic Acid by Human Blood Lymphocytes1 (2000) (101)
- The regulatory and effector roles of eosinophils. (1979) (101)
- Lysophosphatidic Acid Receptor-Selective Effects on Jurkat T Cell Migration Through a Matrigel Model Basement Membrane1 (2001) (101)
- A role for endogenous mono-hydroxy-eicosatetraenoic acids (HETEs) in the regulation of human neutrophil migration. (1980) (99)
- Stimulation of histamine release from human basophils by human platelet factor 4. (1983) (98)
- Vitamin E modulates the lipoxygenation of arachidonic acid in leukocytes (1980) (98)
- Summary and recommendations of a workshop on the investigative use of fiberoptic bronchoscopy and bronchoalveolar lavage in asthmatic patients. (1985) (97)
- Mono- and dihydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils. (1981) (96)
- Effect of eicosapentaenoic acid in asthma (1988) (94)
- Neuroimmune Networks: Physiology and Diseases (1989) (94)
- Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome (2017) (93)
- Gender specificity of altered human immune cytokine profiles in aging (2010) (93)
- Specific suppression by prostaglandin E2 of activation-induced apoptosis of human CD4+CD8+ T lymphoblasts. (1995) (92)
- Nitric Oxide Signaling via Nuclearized Endothelial Nitric-oxide Synthase Modulates Expression of the Immediate Early Genes iNOS and mPGES-1* (2006) (91)
- Altered expression and functional profile of lysophosphatidic acid receptors in mitogen‐activated human blood T lymphocytes (2000) (88)
- Structural and catalytic properties of the solubilized superoxide-generating activity of human polymorphonuclear leukocytes. Solubilization, stabilization in solution, and partial characterization. (1979) (87)
- The role of the polymorphonuclear leukocyte in hyperalgesia (1985) (87)
- Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease (2017) (85)
- Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor (2001) (85)
- Sphingosine 1‐phosphate and its G protein‐coupled receptors constitute a multifunctional immunoregulatory system (2004) (84)
- Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1 (2003) (83)
- Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid (1986) (82)
- "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum. (1975) (77)
- FORMATION OF SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS IN HUMAN LUNG TISSUE AND CELLS BEFORE RELEASE (1974) (76)
- Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. (2001) (75)
- Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome (1984) (74)
- Platelet-derived growth factor stimulates mouse 3T3 cell mitogenesis and leukocyte chemotaxis through different structural determinants. (1983) (73)
- Human plasma platelet‐derived exosomes: effects of aspirin (2016) (73)
- Hyperalgesia onset latency suggests a hierarchy of action (1987) (73)
- Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat. (1988) (73)
- Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2) (2004) (72)
- Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide (2002) (71)
- Isolation and partial characterization of membrane protein constituents of human neutrophil receptors for chemotactic formylmethionyl peptides. (1981) (71)
- Immunologic components of hypersensitivity reactions to cromolyn sodium. (1975) (71)
- Alveolar macrophage lipoxygenase products of arachidonic acid: isolation and recognition as the predominant constituents of the neutrophil chemotactic activity elaborated by alveolar macrophages. (1980) (71)
- Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Sequence and position of a labeled tryptic peptide. (1970) (70)
- Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. (1985) (68)
- Altered cargo proteins of human plasma endothelial cell–derived exosomes in atherosclerotic cerebrovascular disease (2017) (68)
- Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor (1981) (67)
- Immunological Effects of Transgenic Constitutive Expression of the Type 1 Sphingosine 1-Phosphate Receptor by Mouse Lymphocytes1 (2005) (67)
- Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. (1984) (67)
- Nuclear factor‐κB‐dependent reversal of aging‐induced alterations in T cell cytokines (2008) (66)
- Lysophospholipid mediators of immunity and neoplasia. (2002) (66)
- Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors. (1975) (66)
- Stimulus specificity of the generation of leukotrienes by dog mastocytoma cells (1983) (66)
- The human eosinophil: roles in host defense and tissue injury. (1980) (66)
- Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals. (1990) (65)
- Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity. (1975) (65)
- Chemotactic Activity and Receptor Binding of Neutrophil Attractant/Activation Protein‐1 (NAP‐1) and Structurally Related Host Defense Cytokines: Interaction of NAP‐2 With the NAP‐1 Receptor (1991) (63)
- Cellular regulatory role of leukotriene B4: Its effects on cation homeostasis in rabbit neutrophils (1981) (62)
- The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. (1973) (62)
- Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. (1978) (61)
- Lysophospholipid regulation of mononuclear phagocytes. (2002) (61)
- Enhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis. (1983) (61)
- The preferential human mononuclear leukocyte chemotactic activity of the substituent tetrapeptides of angiotensin II. (1980) (61)
- Complement protein levels in plasma astrocyte-derived exosomes are abnormal in conversion from mild cognitive impairment to Alzheimer's disease dementia (2018) (60)
- c-Maf and JunB Mediation of Th2 Differentiation Induced by the Type 2 G Protein-Coupled Receptor (VPAC2) for Vasoactive Intestinal Peptide1 (2004) (60)
- Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways. (1994) (60)
- Aging enhances release of exosomal cytokine mRNAs by Aβ1‐42‐stimulated macrophages (2013) (58)
- Altered levels of plasma neuron‐derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury (2019) (57)
- A physiological approach to the assessment of disease activity in rheumatoid arthritis. (1971) (56)
- Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndrome. (1984) (56)
- Inhibition by leukotriene B5 of leukotriene B4-induced activation of human keratinocytes and neutrophils. (1987) (55)
- Physiological sphingosine 1‐phosphate requirement for optimal activity of mouse CD4+25+ regulatory T Cells (2004) (54)
- Mechanisms of Lysolipid Phosphate Effects on Cellular Survival and Proliferation (2000) (53)
- Cutting Edge: Vasoactive Intestinal Peptide (VIP) Induces Differentiation of Th17 Cells with a Distinctive Cytokine Profile1 (2008) (53)
- Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells. (1988) (52)
- Eicosanoids, but not tachykinins, excite C-fiber endings in rat sciatic nerve-end neuromas. (1992) (52)
- Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. (1996) (52)
- Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging (2016) (52)
- Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challenge. (1989) (51)
- Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4. (1987) (50)
- The conversion of leukotriene C4 to isomers of leukotriene B4 by human eosinophil peroxidase. (1982) (50)
- Endogenous somatostatin-like peptides of rat basophilic leukemia cells. (1985) (50)
- Dual Roles of Substance P: Modulator of Immune and Neuroendocrine Functions a (1987) (49)
- Immunochemical localization of type I VIP receptor and NK-1-type substance P receptor in rat lung. (1995) (47)
- Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis (1976) (47)
- Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11). (1989) (45)
- Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivatives. (1979) (44)
- Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. (2007) (44)
- High-affinity receptors for vasoactive intestinal peptide on human myeloma cells. (1989) (44)
- A sensitive and specific radioimmunoassay for leukotriene C4 (1983) (44)
- Selectivity of Effects of Vasoactive Intestinal Peptide on Macrophages and Lymphocytes in Compartmental Immune Responses a (1998) (43)
- Mast Cell-Derived Mediators: Structural and Functional Diversity and Regulation of Expression (1976) (43)
- Selective expression of 15-lipoxygenase activity by cultured human keratinocytes. (1985) (43)
- IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells. (1983) (43)
- VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. (2011) (43)
- Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. (1983) (43)
- Vasoactive Intestinal Peptide Mediation of Development and Functions of T Lymphocytes (2000) (42)
- Th17 Augmentation in OTII TCR Plus T Cell-Selective Type 1 Sphingosine 1-Phosphate Receptor Double Transgenic Mice1 (2007) (42)
- EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells. (1998) (42)
- Substance P receptor-dependent responses of leukocytes in pulmonary inflammation. (1987) (41)
- Immunological mediators of wound healing and fibrosis (1987) (41)
- Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. (1998) (41)
- Sphingosine 1‐phosphate and its type 1 G protein‐coupled receptor: trophic support and functional regulation of T Lymphocytes (2004) (41)
- Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes. (1998) (41)
- A neutrophil immobilizing factor derived from human leukocytes. II. Specificity of action on polymorphonuclear leukocyte mobility. (1973) (40)
- Astrocyte- and Neuron-Derived Extracellular Vesicles from Alzheimer’s Disease Patients Effect Complement-Mediated Neurotoxicity (2020) (40)
- Pathogenetic roles of neuroimmunologic mediators (1988) (39)
- The 15-lipoxygenase product, 8R,15S-diHETE, stereospecifically sensitizes C-fiber mechanoheat nociceptors in hairy skin of rat. (1990) (39)
- Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. (1976) (39)
- Neuron-derived Plasma Exosome Proteins after Remote Traumatic Brain Injury. (2020) (39)
- Differential default mode network trajectories in asymptomatic individuals at risk for Alzheimer's disease (2019) (38)
- Immunologic release in the rat peritoneal cavity lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes. (1978) (38)
- Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. (1996) (38)
- Lysophospholipid Growth Factors and Their G Protein-Coupled Receptors in Immunity, Coronary Artery Disease, and Cancer (2002) (37)
- Traumatic brain injury increases plasma astrocyte‐derived exosome levels of neurotoxic complement proteins (2020) (37)
- Lipoxygenase-derived products of arachidonic acid mediate stimulation of hexose uptake in human polymorphonuclear leukocytes (1981) (37)
- Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities (1990) (37)
- Integrin‐dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane (1996) (37)
- Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. (1983) (37)
- Constituents of human neutrophils that mediate enhanced adherence to surfaces: purification and identification as acidic proteins of the specific granules. (1980) (36)
- Distinctive T Cell-suppressive Signals from Nuclearized Type 1 Sphingosine 1-Phosphate G Protein-coupled Receptors* (2007) (36)
- Regulation of Expression of Matrix Metalloproteinase-9 in Early Human T Cells of the HSB.2 Cultured Line by the EP3 Subtype of Prostaglandin E2 Receptor* (1996) (36)
- Enzymatic properties of the 15-lipoxygenase of human cultured keratinocytes. (1988) (36)
- Stimulation by leukotriene D4 of increases in the cytosolic concentration of calcium in dimethylsulfoxide-differentiated HL-60 cells. (1987) (35)
- Generation of a unique fibroblast-activating factor by human monocytes. (1984) (35)
- Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes. (1989) (35)
- A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes. (1972) (35)
- A basophil-activating factor from human T lymphocytes. (1984) (34)
- A Natural Variant Type II G Protein-coupled Receptor for Vasoactive Intestinal Peptide with Altered Function* (2004) (34)
- Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology (2019) (33)
- Type 1 Sphingosine 1-Phosphate G Protein-Coupled Receptor (S1P1) Mediation of Enhanced IL-4 Generation by CD4 T Cells from S1P1 Transgenic Mice1 (2007) (33)
- Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid. (1982) (32)
- Protein Kinase C ϵ Dependence of the Recovery from Down-regulation of S1P1 G Protein-coupled Receptors of T Lymphocytes* (2003) (32)
- LASMA AND CELL‐DERIVED INHIBITORS OF HUMAN NEUTROPHIL CHEMOTAXIS (1975) (32)
- Chemotactic Deactivation of Human Eosinophils by the Eosinophil Chemotactic Factor of Anaphylaxis 1 (1975) (32)
- Leukotriene C4 transport by the choroid plexus in vitro. (1985) (31)
- Biochemical regulation of breast cancer cell expression of S1P2 (Edg‐5) and S1P3 (Edg‐3) G protein‐coupled receptors for sphingosine 1‐phosphate (2003) (31)
- Stimulation of human T-lymphocyte chemokinesis by arachidonic acid. (1979) (31)
- Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells. (1995) (30)
- Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. (1999) (30)
- A NEUTROPHIL-DEPENDENT PATHWAY FOR THE GENERATION OF A NEUTRAL PEPTIDE MEDIATOR (1974) (30)
- Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction. (2009) (30)
- Cloning, sequencing and tissue distribution of two related G protein‐coupled receptor candidates expressed prominently in human lung tissue (1995) (29)
- Modulation of human lymphocyte function by C3a and C3a(70-77) (1982) (29)
- Defective responsiveness to ascorbic acid of neutrophil random and chemotactic migration in Felty's syndrome and systemic lupus erythematosus. (1976) (29)
- Deficient neurotrophic factors of CSPG4‐type neural cell exosomes in Alzheimer disease (2018) (29)
- Immunohistochemical localization of peptidergic nerve fibers and neuropeptide receptors in Peyer's patches of the cat ileum (1994) (29)
- Enhancement by vasoactive intestinal peptide of γ‐interferon production by antigen‐stimulated type 1 helper T cells (1999) (28)
- Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy (2019) (28)
- Vasoactive Intestinal Peptide Receptor-1 (VPAC-1) Is a Novel Gene Target of the Hemolymphopoietic Transcription Factor Ikaros* (2002) (28)
- Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4. (1984) (28)
- A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids. (1999) (28)
- Vasoactive Intestinal Peptide. Messenger in a Neuroimmune Axis a (1990) (27)
- Neuropeptide signaling of lymphocytes in immunological responses. (1995) (27)
- Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. (1994) (26)
- Specific Recognition of the Human Neuroendocrine Receptor for Vasoactive Intestinal Peptide by Anti-Peptide Antibodies (1994) (26)
- Identification of neuropeptide-degrading enzymes in the pancreas (1992) (26)
- Novel window on early human neurodevelopment via fetal exosomes in maternal blood (2016) (26)
- Modulation of the random migration of human platelets. (1974) (26)
- Abnormal responses to aspirin of leukocyte oxygenation of arachidonic acid in adults with aspirin intolerance. (1986) (26)
- Sphingosine 1‐phosphate as an intracellular messenger and extracellular mediator in immunity (2007) (25)
- 9 – Biochemical and Cellular Characteristics of the Regulation of Human Leukocyte Function by Lipoxygenase Products of Arachidonic Acid (1984) (25)
- Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B. (1975) (25)
- SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19 (2022) (25)
- A Lymphocyte-Generated Fragment of Vasoactive Intestinal Peptide with VPAC1 Agonist Activity and VPAC2 Antagonist Effects (2003) (25)
- Vasoactive Intestinal Peptide–Mediated Th17 Differentiation (2008) (25)
- Neuropeptides in pulmonary edema fluid of adult respiratory distress syndrome (1992) (24)
- Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells. (1993) (24)
- Stimulus-specificity of the chemotactic deactivation of human neutrophils by lipoxygenase products of arachidonic acid. (1981) (24)
- Active site chemotactic factors and the regulation of the human neutrophil chemotactic response. (1974) (23)
- The immunological generation of a platelet-activating factor and a platet-lytic factor in the rat. (1979) (23)
- Chemotactic factor receptors of human PMN leucocytes. I. Effects on migration of labelling plasma membrane determinants with impermeant covalent reagents and inhibition of labelling by chemotactic factors. (1979) (23)
- Type 1 sphingosine 1‐phosphate G protein‐coupled receptor signaling of lymphocyte functions requires sulfation of its extracellular amino‐terminal tyrosines (2005) (23)
- Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC) (1987) (23)
- Selective modulation by guanine nucleotides of the high affinity subset of plasma membrane receptors for leukotriene B4 on human polymorphonuclear leukocytes. (1988) (23)
- The development of a radioimmunoassay for 12-L-hydroxyeicosatetraenoic acid. (1980) (23)
- Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease (2021) (22)
- Generation and Recognition of Vasoactive Intestinal Peptide by Cells of the Immune System (1990) (21)
- Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder (2021) (21)
- Regulation of the roles of sphingosine 1-phosphate and its type 1 G protein-coupled receptor in T cell immunity and autoimmunity. (2008) (21)
- Growth Hormone-Releasing Hormone Modulation of Neuronal Exosome Biomarkers in Mild Cognitive Impairment. (2018) (21)
- A novel eosinophil chemotactic factor derived from a histiocytic lymphoma of the central nervous system. (1980) (21)
- Suppression by ingested eicosapentaenoic acid of the increases in nasal mucosal blood flow and eosinophilia of ryegrass-allergic reactions. (1990) (21)
- Neuroimmune Interactions in the Lung (1992) (21)
- Lysophospholipids and their G protein‐coupled receptors in biology and diseases (2004) (21)
- Prostaglandin-generating factor of anaphylaxis induces mucous glycoprotein release and the formation of lipoxygenase products of arachidonate from human airways. (1984) (21)
- Specificity and cellular distribution of human polymorphonuclear leucocyte receptors for leukotriene C4. (1987) (20)
- Identification of leukotriene B4 as the neutrophil chemotactic factor released by antigen challenge from passively sensitized guinea pig lungs. (1989) (20)
- Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide. (1993) (20)
- Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. (1993) (20)
- Production and Recognition of Neuropeptides by Cells of the Immune System (1991) (19)
- Stem cell factor influences neuro-immune interactions: The response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factor (1999) (19)
- Lysophospholipids and eicosanoids in biology and pathophysiology (2000) (19)
- Lysophospholipid enhancement of human T cell sensitivity to diphtheria toxin by increased expression of heparin-binding epidermal growth factor. (1999) (19)
- TWO FORMS OF MACROAMYLASÆMIA (1968) (19)
- Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC). (1983) (19)
- Differential Signaling of T Cell Generation of IL-4 by Wild-Type and Short-Deletion Variant of Type 2 G Protein-Coupled Receptor for Vasoactive Intestinal Peptide (VPAC2)1 (2006) (19)
- Regulation of epithelial electrolyte transport by metabolites of arachidonic acid. (1984) (19)
- Leukotrienes in the aqueous humor of patients with uveitis. (1986) (19)
- Neuropeptide regulation of immediate and delayed hypersensitivity. (1988) (19)
- Multicellular hypothesis for the pathogenesis of Alzheimer's disease (2017) (18)
- Effects of intra-articular corticosteroids in vivo on synovial fluid variables in rheumatoid synovitis. (1974) (18)
- Changes in adhesion molecule expression during distinct patterns of immune cell migration in the inflamed lung. (1996) (18)
- An acidic fibroblast growth factor protein generated by alternate splicing acts like an antagonist (1992) (18)
- Elevated synovial tissue concentration of the common acute lymphoblastic leukaemia antigen (CALLA)-associated neutral endopeptidase (3.4.24.11) in human chronic arthritis. (1990) (18)
- Receptor‐specific Mechanisms for the Responses of Human Leukocytes to Leukotrienes a (1988) (17)
- Unique determinants of alveolar macrophage spontaneous and chemokinetically stimulated migration. (1978) (17)
- Identification of the platelet activating activity in rheumatoid synovial fluid as an intermediate molecular weight complex of IgG. (1979) (17)
- Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung. (1974) (17)
- Endomyocardial disease and eosinophilia. Report of a case. (1978) (17)
- Stimulation of hexose uptake by human eosinophils with chemotactic factors. (1981) (17)
- Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. (1991) (17)
- Preferential enhancement of older human T cell cytokine generation, chemotaxis, proliferation and survival by lenalidomide. (2011) (17)
- Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis. (1978) (17)
- Endothelial‐derived plasma exosome proteins in Alzheimer’s disease angiopathy (2020) (17)
- Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: Transduction of both Ca2+ and cyclic AMP signals (2005) (16)
- Leukotriene C4 Transport and Metabolism in the Central Nervous System (1986) (16)
- Protein kinase C epsilon dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. (2003) (16)
- Decreased mitochondrial electron transport proteins and increased complement mediators in plasma neural-derived exosomes of early psychosis (2020) (16)
- Brain Aβ load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD (2019) (16)
- Distinctive immunoregulatory effects of adenosine on T cells of older humans (2012) (16)
- “Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders (2018) (16)
- The extracellular and intracellular roles of hydroxy-eicosatetraenoic acids in the modulation of polymorphonuclear leukocyte and macrophage function. (1980) (16)
- Inhibition of complement-mediated functions of human neutrophils by impermeant stilbene disulfonic acids. (1981) (16)
- Role of concentrative leukotriene transport systems in the central nervous system. (1986) (16)
- Neural cell‐derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis (2021) (15)
- Development of receptors for leukotriene B4 on HL-60 cells induced to differentiate by 1 alpha,25-dihydroxyvitamin D3. (1986) (15)
- Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunologic release, granule association, and demostration of structura heterogeneity. (1978) (15)
- Interleukin‐3 modulation of mouse bone marrow derived mast cell receptors for somatostatin (1987) (15)
- Diverse Mechanisms and Consequences of Immunoadoption of Neuromediator Systems (2008) (15)
- The SKW 6.4 line of human B lymphocytes specifically binds and responds to vasoactive intestinal peptide. (1993) (15)
- Chemotactic Factors, Neuropeptides, and Other Ligands for Seven Transmembrane (2000) (14)
- Functional Splice Variants of the Type II G Protein–Coupled Receptor (VPAC2) for Vasoactive Intestinal Peptide in Mouse and Human Lymphocytes (2006) (14)
- Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen (1988) (14)
- Leukocyte recognition and metabolism of leukotrienes. (1983) (14)
- A chemotactic receptor for val(ala)-gly-ser-glu on human. (1976) (13)
- Immunopathogenetic roles of leukotrienes in human diseases (1984) (13)
- An IgM-kappa rat monoclonal antibody specific for the type 1 sphingosine 1-phosphate G protein-coupled receptor with antagonist and agonist activities. (2004) (13)
- Sulfidopeptide-leukotriene peptidases in pulmonary edema fluid from patients with the adult respiratory distress syndrome (1988) (13)
- Recognition of leukotriene B4 by a unique subset of human T-lymphocytes. (1984) (13)
- Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease (2021) (13)
- Total absence of eosinophils in a patient with an allergic disorder. (1981) (13)
- Immunosuppressive human anti‐lymphocyte autoantibodies specific for the type 1 sphingosine 1‐phosphate receptor (2009) (13)
- Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies. (1980) (13)
- Immunologic alterations in bovine serum albumin resulting from partial or complete reduction and alkylation. (1972) (12)
- Down-regulation of receptor antigen in leukotriene B4-induced chemotactic deactivation of human polymorphonuclear leucocytes. (1991) (12)
- Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury (2020) (12)
- Modulation of human eosinophil polymorphonuclear leukocyte migration and function. (1976) (12)
- Characteristics of the epitope of leukotriene B4 recognized by a highly specific mouse monoclonal antibody. (1984) (12)
- Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4. (1987) (12)
- MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints (2021) (11)
- A neutrophil-dependent pathway for the generation of a neutral peptide mediator. II. Subcellular localization of the neutrophil protease. (1977) (11)
- Circulating eosinophil colony-forming cells in pure eosinophil aplasia. (1984) (11)
- The Omnific Lysophospholipid Growth Factors (2000) (11)
- Structural diversity of the fibroblast-activating factors generated by human blood monocytes and U937 cells. (1985) (11)
- Hypothesis: VPAC G protein-coupled receptors for vasoactive intestinal peptide constitute a dynamic system for signaling T cells from plasma membrane and nuclear membrane complexes (2006) (10)
- Human CD4 8 T cells are a distinctive immunoregulatory subset (2010) (10)
- Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers (2020) (10)
- Distinct energy requirements for human memory CD4 T‐cell homeostatic functions (2013) (10)
- In vivo and in vitro assessment of the role of leukotriene B4 as a mediator of rat cutaneous late-phase reactions. (1986) (10)
- Arachidonic acid and hexose transport in human polymorphonuclear leukocytes. (1981) (10)
- Mast cell-mediated reactions of host defense and tissue injury (1977) (9)
- Cellular generation, transport, and effects of eicosanoids : biological roles and pharmacological intervention (1994) (9)
- Specific effects on human neutrophils of antibodies to a membrane protein constituent of neutrophil receptors for chemotactic formyl-methionyl peptides. (1982) (9)
- Changing paradigms in the immunological science of allergy (2007) (9)
- Specificity and Modulation of the Eosinophil Polymorphonuclear Leukocyte Response to the Eosinophil Chemotactic Factor of Anaphylaxis (ECF-A) (1976) (9)
- Inhibition of human neutrophil receptor-mediated uptake of N-formyl-met-leu-phe by platelet factor 4 (59-70). (1985) (8)
- Unique characteristics of superoxide production by human eosinophils in eosinophilic states (1979) (8)
- Studies of immediate hypersensitivity in a patient with Acanthocheilonema perstans filarial infection. (1975) (8)
- Ascorbate therapy in impaired neutrophil and monocyte chemotaxis. With atopy, hyperimmunoglobulinemia E, and recurrent infection. (1978) (8)
- Leukotriene D4‐induced increases in the cytoplasmic pH of human myelocytic leukocytes (1988) (7)
- Generation and recognition of leukotriene mediators of hypersensitivity and inflammation (1988) (7)
- Defective T Cell Chemotaxis to Sphingosine 1-Phosphate and Chemokine CCL21 in Idiopathic T Lymphocytopenia (2011) (7)
- Generation, Function, and Disposition of Chemical Mediators of the Mast Cell in Immediate Hypersensitivity (1977) (7)
- The dependence of human T-lymphocyte migration on the 5-lipoxygenation of endogenous arachidonic acid (1981) (7)
- Changing paradigms in the immunological science of allergy: 2008 (2007) (7)
- Advancing medicine for Alzheimer’s disease: A plasma neural exosome platform (2020) (7)
- Cellular characteristics of the eosinophil compatible with a dual role in host defense in parasitic infections. (1977) (6)
- Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B 4 ( leukocyte / lipoxygenase / hydroxyicosatetraenoic acid / immunosuppression / hypersensitivity ) (6)
- This information is current as Bax Apoptosis in Association with Suppression of 1-Phosphate Protection of T Cells from Lysophosphatidic Acid and Sphingosine (1999) (6)
- Preface: the omnific lysophospholipid growth factors. (2000) (6)
- Inhibition of expression of the type I G protein-coupled receptor for vasoactive intestinal peptide (VPAC1) by hammerhead ribozymes. (2000) (6)
- Recovery of greater antigenic reactivity in conformationally altered albumin. (1969) (6)
- Leukotrienes in pulmonary edema fluid after cardiopulmonary bypass. (1986) (6)
- The predominant contribution of platelets to baseline and ascorbate-stimulated increments in cyclic GMP in human mononuclear leukocyte preparations. (1978) (6)
- Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans (2021) (6)
- Elevation of the cyclic GMP concentration in human platelets by sodium ascorbate and 5-hydroxytryptamine. (1977) (5)
- Reduction in pulmonary fibroblast-stimulating activity as an index of response to treatment of interstitial lung diseases. (1990) (5)
- Isolation and partial characterization of a fibroblast-activating factor generated by U-937 human monocytic leukocytes. (1988) (5)
- Diverse Mechanisms of Specificity of Human Receptors for Eicosanoids a (1994) (5)
- Mediation of prolonged increases in nasal mucosal blood flow by calcitonin gene-related peptide (CGRP) (1990) (5)
- Receptor-Dependent Regulation of Human Polymorphonuclear Leukocyte Responses to Leukotrienes (1987) (5)
- Current perspectives in allergy (1982) (5)
- CHAPTER 13 – EFFECTS OF EICOSAPENTAENOIC ACID ON IMMUNE RESPONSES AND INFLAMMATION IN HUMANS1 (1986) (5)
- Sequential alterations in the human eosinophil content of arylsulfatase B during therapy of Bancroftian filariasis. (1981) (5)
- Inflammation and Hypersensitivity (1985) (5)
- 482 Unique suppression of human blood mononuclear leukocyte (ML) production of IgG by prolonged exposure to vasoactive intestinal peptide (VIP) (1991) (5)
- Substrate protection of lactic acid dehydrogenase against inactivation by ionizing radiation. (1968) (5)
- Mouse monoclonal antibody to a latent epitope of leucocyte receptors for leukotriene B4. (1992) (5)
- A phagocytosis-enhancing factor in human plasma. (1976) (4)
- Alternative Signaling of TH17 Cell Development by Sphingosine 1-Phosphate (S1P) (90.2) (2007) (4)
- Is Aging a Drug Target? (2011) (4)
- Relative quantification of collagen mrna in fibroblasts by a radioactive polymerase chain reaction technique (1991) (4)
- Research Article Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study (2014) (4)
- Selective immobilization of human mononuclear phagocytes by benoxaprofen. (1982) (4)
- PATHOGENIC PROTEINS IN NEURALLY-DERIVED BLOOD EXOSOMES AS NEAR-PERFECT DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR ALZHEIMER'S DISEASE (2014) (4)
- Inhibition by Aspirin of the Enhanced Migration of Human Platelets in Response to Prostaglandin Precursors (1975) (4)
- Two forms of macroamylasaemia. (1968) (4)
- Nerve–Mast Cell Interactions—Partnership in Health and Disease (2003) (4)
- Modulation of the PMN Leukocyte Component of Hypersensitivity Reactions by Lipoxygenase Products of Arachidonic Acid (1981) (4)
- Polymerase chain reaction amplification of messages for growth factors in cells from human bronchoalveolar lavage fluids (1991) (4)
- Molecular and cellular diversity of the polymorphonuclear leukocyte receptors for leukotrienes. (1987) (3)
- Endothelial-derived exosomes demonstrate a link between endothelial innate inflammation and brain dysfunction and injury in aging (2019) (3)
- Altered Functional Mitochondrial Protein Levels in Plasma Neuron-Derived Extracellular Vesicles of Patients With Gadolinium Deposition (2022) (3)
- Inhibition by non-steroidal anti-inflammatory agents of the ascorbate-induced elevations of platelet cyclic AMP levels. (1979) (3)
- Characteristics of Human Leukocyte Receptors for Leukotrienes (1983) (3)
- Immunoregulatory lysophospholipids: new stars in the mast cell constellation (2004) (3)
- Acute Insulin Resistance and Rapid Alterations in Neuronal Derived Blood Exosome Concentration After Branched Endovascular Aortic Aneurysm Repair. (2019) (3)
- Cytosolic localization of the 15 lipoxygenase of human neonatal foreskin keratinocytes (1986) (3)
- Lenalidomide enhancement of human T cell functions in human immunodeficiency virus (HIV)‐infected and HIV‐negative CD4 T lymphocytopenic patients (2012) (3)
- Ligand‐induced formation of the leukotriene B4 receptor‐G protein complex of human polymorphonuclear leukocytes (1992) (3)
- Molecular diversity of human leukocyte receptors. (1989) (3)
- EP 4 / EP 2 Receptor-Specific Prostaglandin E 2 Regulation of Interleukin-6 Generation by Human HSB . 2 Early T Cells 1 (1998) (3)
- Structural requirements for the activity of an immunologically generated lipid chemotactic factor. (1980) (3)
- Neuroimmune Networks: Physiology and Diseases Library of Congress Cataloging-in-publication Data (2)
- Antisense oligonucleotide suppression of expression of VIP receptors in diverse intestinal cells (1998) (2)
- Leukocyte receptors for lipid and peptide mediators. (1987) (2)
- Diminished levels of cellular protective factors present in neurally enriched exosomes in preclinical Alzheimer’s disease (2015) (2)
- Current Perspectives in the Immunology of Respiratory Diseases (1986) (2)
- Diverse responses of human fibroblasts to a highly purified fibroblast-activating factor from the U937 line of human monocytes. (1989) (2)
- Abnormal levels of mitochondrial Ca2+ channel proteins in plasma neuron‐derived extracellular vesicles of early schizophrenia (2022) (2)
- Neuroregulation of Pulmonary Immune Responses by Vasoactive Intestinal Peptide and Substance P (1998) (2)
- Appearance of neuropeptides in ascitic fluid after peritoneal therapy with interleukin-2 and lymphokine-activated killer cells for intraabdominal malignancy (1989) (2)
- Mediation of pulmonary immunity and hypersensitivity by neuropeptides. (1986) (2)
- 315 Patterns of LTC4 release in human allergic skin reactions (1985) (2)
- First International Conference on Lysophospholipids and Related Bioactive Lipids in Biology and Disease Sponsored by the Federation of American Societies of Experimental Biology (2001) (1)
- Specfficity of expression and effects of eicosanoid (1995) (1)
- PREDICTION OF CONVERSION OF MILD COGNITIVE IMPAIRMENT TO DEMENTIA WITH NEURONALLY DERIVED BLOOD EXOSOME PROTEIN PROFILE (2016) (1)
- Long-COVID: Phase 2 of the COVID-19 Pandemic (2022) (1)
- Distinctive T Cell Suppressive Signals from Nuclearized Type 1 Sphingosine 1‐Phosphate G Protein‐Coupled Receptors (2007) (1)
- Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathy (1984) (1)
- Aging enhances release of exosomal cytokine mRNAs by A (cid:1) 1-42 -stimulated macrophages (2013) (1)
- 481 Vasoactive intestinal peptide inhibits phorbol ester-enhanced IgM synthesis in a human B cell line (1991) (1)
- Navigating the sea of eicosanoids. (1985) (1)
- Recognition of the ligand-binding site of human neutrophil (N) receptors for leukotriene B/sub 4/ (LTB/sub 4/) by antibodies to idiotypes (anti-Ids) of mouse monoclonal anti-LTB/sub 4/ (1986) (1)
- Vasoactive intestinal peptide enhancement of antigen‐induced differentiation of a cultured line of mouse thymocytes (1998) (1)
- Fractionated total lymphoid irradiation can induce temporary relief in refractory rheumatoid arthritis. (1981) (1)
- Molecular Properties of Leukocyte Receptors for Leukotrienes (1988) (1)
- THE GENERATION OF CHEMOTACTICACTIVITY BY ACTIVATION OF PLASMINOGEN PROACTIVATOR (1)
- Activation of human neutrophil LFA-1 (CD11a) by leukotriene B4 (1993) (1)
- NHLBI workshop summaries. Neuroimmune interactions in the lung. (1992) (1)
- Molecular characteristics of the cellular receptor for vasoactive intestinal peptide. (1991) (1)
- Neural origin plasma exosomes provide novel biomarkers for brain insulin resistance in Alzheimer's disease (S33.003) (2015) (1)
- VIP and PACAP receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
- Receptor-dependent inhibition by vasoactive intestinal peptide of phorbol ester-enhanced IgM secretion by a human B cell line (1991) (1)
- Isolation and partial characterization of the structures of fibroblast activating factor-related proteins from U937 cells. (1991) (1)
- Defective responsiveness toascorbic acid ofneutrophil randomandchemotactic migration inFelty's syndromeand systemic lupuserythematosus (1976) (0)
- Specialized excitatory synaptic protein biomarkers of plasma neuronal exosomes for prediction and staging of alzheimer's disease (2018) (0)
- CD4+T cell-dependent cytokine-mediated deviation of hypersensitivity by the inducible type II receptor (VPAC2) for vasoactive intestinal peptide (VIP). (2002) (0)
- Transgenic Mice 1 from S1P of Enhanced IL-4 Generation by CD4 T Cells ) Mediation 1 Protein-Coupled Receptor (S1P Type 1 Sphingosine 1-Phosphate G (2007) (0)
- Specific inhibition of receptor-dependent human cellular responses by antisense mRNA depletion of individual G-proteins. (1993) (0)
- VASOACnVE INTESTINAL PEPTIDE TYPE H RECEPTORSPECIFIC ENHANCEMENT of MOUSE THYMOCYTE DIFFERENTIATION to CD4 SINGLE POSITIVE T CELLS (1997) (0)
- 291 Distinct patterns of appearance of neuropeptides in acute inflammatory reactions of the human lung (1991) (0)
- Author Correction: Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans (2022) (0)
- NEURONALLY-DERIVED EXOSOMAL PROTEINS CAN PREDICT BRAIN AMYLOIDOSIS (2016) (0)
- Vasoactive intestinal peptide (VIP) up-regulates IL-17 generation by mouse CD4 T cells (100.1) (2007) (0)
- Selective enhancement of expansion and function of Th17 cells by sphingosine 1‐phosphate and its type I G protein‐coupled receptor (2007) (0)
- Preface (2008) (0)
- 15-, 12-, and 5-lipoxygenase products of arachidonic acid differ between two canine mastocytoma cell lines (1985) (0)
- Neuropeptide Mediators of Neuro-Immune Communications (2003) (0)
- Allergy: leukotrienes. (1987) (0)
- Sphingosine 1 phosphate (S1P) -Type 1 Sphingosine 1-Phosphate G Protein-Coupled Receptor (S1P1) axis promotes peripheral generation of CD4+CD25+ regulatory T cells (131.5) (2007) (0)
- Arthritis: recent advances in theory and therapy. (1982) (0)
- NEURONALLY-DERIVED EXOSOMAL PROTEINS CAN PREDICT BRAIN AMYLOIDOSIS (2016) (0)
- Lipoxygenbase-derived products of arachidonic acid mediate stimulation of hexose uptake in human polymorphonuclear leukocytes. (1981) (0)
- Modulation oftheImmunological Release oftheEosinophil Chemotactic Factor ofAnaphylaxis fromHumanLung (1974) (0)
- Biomarkers of brain insulin resistance and neuroimaging correlates in early Alzheimer's disease (2015) (0)
- Issue Information (2020) (0)
- EP Receptor Subtype-Dependence of Regulation of Immune Cellular Functions by Prostaglandin E2 (1996) (0)
- β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification (2020) (0)
- Biochemical and Cellular Characteristics of Mononuclear Leukocyte Chemotaxis (1981) (0)
- Subject Index to Volume 15 (2001) (0)
- Increased susceptibility to colitis in the Vasoactive Intestinal Peptide receptor type 2 (VPAC2) mouse : A negative role for VPAC1 receptor in the induction of intestinal inflammation (50.44) (2009) (0)
- An Acidic Fibroblast Growth Factor Protein Generated by Alternate Splicing Acts Like an Antagonis t (2003) (0)
- Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19 (2023) (0)
- GOETZL AND PICKETT BRIEF DEFINITIVE REPORT 487 activity of arachidonic acid lipoxygenase products on leucocytes of different species (2003) (0)
- Neural signaling opportunities for novel diagnostic approaches and therapies. Preface. (2008) (0)
- BIOMARKERS SUGGESTACTIVATION OF INNATE IMMUNITY IN SUBCLINICAL CEREBROVASCULAR DISEASE (2018) (0)
- LEUKOTRIENES BY DOG MASTOCYTOMA CELLS (1983) (0)
- Estrogen-Modulated Response of Breast Cancer to Vitamin D and its Analogs: Role of IGF (1999) (0)
- Induction of Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells (2001) (0)
- 111: Probing early human neural development through fetal exosomes in maternal blood (2016) (0)
- Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene (G protein-coupled receptors/type II pituitary adenylyl cyclase-activating peptide receptor/secretin receptor/chromosome 3p22) (2016) (0)
- Isolation of labeled peptide from affinity labeled mouse myeloma protein 315. Abstr. (1970) (0)
- Changing paradigms in the immunologic science of allergy (2006) (0)
- GROWTH HORMONE–RELEASING HORMONE (GHRH) ADMINISTRATION IN MILD COGNITIVE IMPAIRMENT MODULATES PHOSPHORYLATED TAU IN NEURONALLY-DERIVED EXOSOMES (2016) (0)
- Pertussis Toxin Catalyzed ADP-ribosylation of PMNL Homogenates (2003) (0)
- Mechanisms of leukotriene B4-specific chemotactic deactivation of human polymorphonuclear leukocytes. (1991) (0)
- Vasoactive intestinal peptide (VIP) up-regulates IL-17 generation by mouse CD4 T cells (2007) (0)
- Vasoactive intestinal peptide (VIP) induces differentiation of unique Th17 cells independently of IL‐6 and IL‐21 (2008) (0)
- The binding of lipid and peptide chemotactic factors to cell surface receptors on polymorphonuclear leukocytes (PMNL) l initiates a series of intracellular biochemical events that lead to increased chemokinetic and chemotactic migra- (2003) (0)
- Drug efficacy test method for dementias utilizing astrocyte-derived exosomes (2017) (0)
- Author response: Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury (2020) (0)
- An Acidic Fibroblast Growth Factor Protein Generated by Alternate Splicing Acts Like an (1992) (0)
- by Sphingosine 1-Phosphate Cutting Edge: Suppression of T Cell Chemotaxis (2002) (0)
- Neuroregulation of Pulmonary Immunity: The Roles of Substance P and Vasoactive Intestinal Peptide (2017) (0)
- Lysophosphatidic Acid by Human Blood Expression of Functional Receptors for Cutting Edge: Differential Constitutive (2000) (0)
- Transgenic Mice Cell-Targeted Type II VIP Receptor Phenotypes by Wild-Type Mice and T in the Expression of Different Immune Roles of Vasoactive Intestinal Peptide (VIP) (2002) (0)
- Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study (2020) (0)
- PerOXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐α‐MEDIATED GENE EXPRESSION AND ADAPTATION TO FATTY ACID OVERLOAD IN ALCOHOLIC LIVER DISEASE (1998) (0)
- ENDOTHELIAL-DERIVED EXOSOME BIOMARKERS SUGGEST ACTIVATION OF INNATE IMMUNITY IN SUBCLINICAL CEREBROVASCULAR DISEASE (2018) (0)
- Issue Information (2020) (0)
- Polypeptide structure of a human dermal fibroblast-activating factor (FAF) derived from the U937 cultured line of human monocyte-like cells (1986) (0)
- Neuromediators of Immunity and Inflammation (1989) (0)
- LymphocytesSphingosine 1-Phosphate Receptor by Mouse Constitutive Expression of the Type 1 Immunological Effects of Transgenic (2005) (0)
- Mechanisms for Diversification of Responses of Human Polymorphonuclear Leukocytes to Leukotrienes (1990) (0)
- Coupling of vasoactive intestinal peptide type n receptor (VIPR2) to signal transducers and activators of transcription (stats) in human t cells (1996) (0)
- Solubilization and cleavage of human neutrophil (N) affinity-labeled receptors for leukotriene B/sub 4/ (LTB/sub 4/) (1986) (0)
- Book Reviews (1917) (0)
- Neuroalternative Enhancement of Development of Th17 Cells by Signals from the Type 1 Receptor for Vasoactive Intestinal Peptide (VPAC1) (95.11) (2007) (0)
- Biomarkers of brain insulin resistance and neuroimaging correlates in early Alzheimer's disease (2015) (0)
- Mice 1-Phosphate Receptor Double Transgenic Cell-Selective Type 1 Sphingosine Th 17 Augmentation in OTII TCR Plus T (2007) (0)
- Calcium dynamics in stimulation of human polymorphonuclear leukocytes by leukotriene B4. (1985) (0)
- Immediate Immunologie Reaetions: Noneytolytie Mediator Release and Cytolytie Cell Destruetion* (1972) (0)
- Lipid mediators of leukocyte function in immediate-type hypersensitivity reactions. (1981) (0)
- Sphingosine 1‐phosphate and interleukin‐4 signaling requirements for peripheral conversion of naïve T cells to adaptive CD4+25+ regulatory T cells (2008) (0)
- Lysophospholipid Receptors and Effects in Breast Cancer (2001) (0)
- EXTRACELLULAR VESICLE-BASED BIOMARKERS FOR ALZHEIMER’S DISEASE IN THE BALTIMORE LONGITUDINAL STUDY OF AGING (2018) (0)
- VPAC Receptor for Vasoactive Intestinal Peptide Variant of Type 2 G Protein-Coupled IL-4 by Wild-Type and Short-Deletion Differential Signaling of T Cell Generation of (2006) (0)
- C‐maf, JunB, and Gata3 mediation of IL‐4 up‐regulation in CD4 T cells from Type 1 Sphingosine 1‐phosphate receptor (S1P1) transgenic (TG) mice (2006) (0)
- Receptor G Protein-Coupled 1 Functions by the S1P Sphingosine 1-Phosphate (S1P) on T Cell Transduction of Multiple Effects of (2003) (0)
- Sphingosine 1 phosphate (S1P) -Type 1 Sphingosine 1-Phosphate G Protein-Coupled Receptor (S1P1) axis promotes peripheral generation of CD4+CD25+ regulatory T cells (2007) (0)
- Neuronal origin plasma exosomes provide novel biomarkers for lysosomal dysfunction in Alzheimer’s disease (2015) (0)
- Chemotactic activity of components of the kallikrein-kinin system (1975) (0)
- Lipid and peptide mediators of inflammation. Summary. (1983) (0)
- Vasoactive Intestinal Peptide ) for 2 Protein-Coupled Receptor ( VPAC Differentiation Induced by the Type 2 G c-Maf and JunB Mediation of Th 2 Dolganov (2004) (0)
- Receptor for Lysophosphatidic Acid in Ovarian Cancer Endothelial Differentiation Gene-encoded G Protein-coupled Distinctive Expression and Functions of the Type 4 Updated (1999) (0)
- Molecular and cellular mechanisms of human hypersensitivity and autoimmunity : proceedings of a Cetus-Upjohn-UCLA Symposium, held at Keystone, Colorado, April 17-23, 1988 (1989) (0)
- Immediate Immunologic Reactions: Noncytolytic Mediator Release and Cytolytic Cell Destruction (1972) (0)
- Induction of Experimental Autoimmune Encephalomyelitis (EAE) in type 1 Sphingosine 1‐Phosphate Receptor (S1P1) Transgenic Mice (2006) (0)
- Aging‐Induced NF‐κB‐Dependent Alterations in T Cell Cytokines (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edward J. Goetzl?
Edward J. Goetzl is affiliated with the following schools:
